| |
|
|
|
NovaBay Pharmaceuticals Inc.  
|
|
0.298216 0.011 (0.04%) |
05-23 15:57 |
|
Open: |
0.29 |
Pre close: |
0.2874 |
Target:
|
0.98
|
|
High: |
0.4 |
Low: |
0.27 |
Resistance:
|
0.84
1.22
|
|
Volume: |
1,671,825 |
Market Cap: |
6M |
Support:
|
0.23
0.19
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.33
 |
MACD |
MACD(12,26):
|
-0.20 |
|
MA(20): |
0.66 |
Signal(12,26,9): |
-0.17 |
|
MA(100): |
1.19 |
Stochastic Oscillator |
%K(14,3):
|
8.07 |
|
MA(250): |
1.55 |
%D(3): |
10.07 |
|
Average Volume(K) |
3-Month: |
46782
|
52-Week |
High:
|
3.75 |
|
10-Days: |
257170 |
Low: |
0.23 |
|
RSI |
RSI(14):
|
34.11  |
Change(%): |
-88.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.490 |
Return on Equity (ttm) |
-218.3 |
Shares Out. (M) |
18.99 |
|
EPS Est. Current Year |
-0.470 |
Return on Assets (ttm) |
-82.4 |
Shares Float (M) |
17.21 |
|
EPS Est. Next Year |
-0.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
-49.4 |
% Held by Institutions |
1.20 |
|
Forward EPS |
-0.170 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
68 |
|
Book Value (p.s.) |
21.300 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.61 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.01 |
|
Profit Margin |
-84.37 |
Operating Cash Flow
(M) |
0.00 |
P/S |
7909605.00 |
|
Operating Margin |
-86.63 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
